Zhang Yun-Xing, Wang Qian-Qian, Huang Chen-Bin, Duan Jun-Li, Li Ling-Tong, Zhang Jian-Wen
College of Anesthesiology, Shanxi Medical University, Taiyuan, Shanxi, China.
Department of Anesthesiology, Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, Shanxi, China.
J Perianesth Nurs. 2025 Jul 11. doi: 10.1016/j.jopan.2025.04.014.
The purpose of this study is to evaluate the effects of thoracic paravertebral block (TPVB) on postoperative analgesia and recovery quality in individuals undergoing daytime laparoscopic partial adrenalectomy.
A prospective, randomized, double-blind study.
A total of 65 patients scheduled for daytime laparoscopic partial adrenalectomy were randomly assigned to the TPVB group or the control group. After surgery and before extubation, the patients in the TPVB group received TPVB, while those in the control group did not undergo the intervention. The primary outcome was the Quality of Recovery-15 assessed at 24 and 48 hours postoperatively. Secondary outcomes included postoperative pain intensity measured using the visual analog scale (VAS), cumulative sufentanil consumption, rescue analgesia rate, intake, feeling nauseated, emesis, exam, duration of symptoms scores, first flatus and defecation time, and the incidence of postoperative nausea and vomiting.
The TPVB group demonstrated significantly higher Quality of Recovery-15 scores at 24 and 48 hours after surgery compared with the control group (all P < .05). The sufentanil consumption within 48 hours after surgery was reduced in the TPVB group (P = .002), as was the rate of rescue analgesia within 48 hours (P = .045). VAS scores for pain at rest were significantly decreased in the TPVB group at 1, 6, 12, and 24 hours postoperatively (all P < .05), while VAS pain scores during coughing were lower at 1, 6, and 12 hours (all P < .05). The TPVB group also exhibited lower intake, feeling nauseated, emesis, exam, duration of symptoms scores at 12, 24, and 48 hours after surgery (all P < .05). The time to first flatus and defecation was shorter in the TPVB group compared with the control group (all P < .05). Furthermore, the incidence of postoperative nausea and vomiting was lower in the TPVB group compared with the control group (P = .035).
These results indicated that TPVB enhances postoperative analgesia, improves gastrointestinal function, and promotes the quality of recovery in patients undergoing daytime laparoscopic partial adrenalectomy.
本研究旨在评估胸椎旁神经阻滞(TPVB)对日间腹腔镜下肾上腺部分切除术患者术后镇痛及恢复质量的影响。
一项前瞻性、随机、双盲研究。
总共65例计划行日间腹腔镜下肾上腺部分切除术的患者被随机分配至TPVB组或对照组。手术结束后且拔管前,TPVB组患者接受TPVB,而对照组患者不接受该干预措施。主要结局指标为术后24小时和48小时评估的恢复质量-15(Quality of Recovery-15)。次要结局指标包括使用视觉模拟量表(VAS)测量的术后疼痛强度、舒芬太尼累积用量、补救性镇痛率、摄入量、恶心感、呕吐、检查、症状持续时间评分、首次排气和排便时间以及术后恶心呕吐的发生率。
与对照组相比,TPVB组在术后24小时和48小时的恢复质量-15评分显著更高(所有P <.05)。TPVB组术后48小时内的舒芬太尼用量减少(P =.002),48小时内的补救性镇痛率也降低(P =.045)。术后1、6、12和24小时,TPVB组静息时的VAS疼痛评分显著降低(所有P <.05),而咳嗽时的VAS疼痛评分在1、6和12小时更低(所有P <.05)。TPVB组在术后12、24和48小时的摄入量、恶心感、呕吐、检查、症状持续时间评分也更低(所有P <.05)。与对照组相比,TPVB组首次排气和排便的时间更短(所有P <.05)。此外,TPVB组术后恶心呕吐的发生率低于对照组(P =.035)。
这些结果表明,TPVB可增强日间腹腔镜下肾上腺部分切除术患者的术后镇痛效果,改善胃肠功能,并提高恢复质量。